Herbalife (HLF) Cash & Equivalents (2009 - 2026)

Herbalife has disclosed Cash & Equivalents across 18 years of filings, most recently posting $451.2 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $451.2 million, up 28.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $451.2 million (up 28.55% YoY), and the FY2025 annual result was $353.1 million, down 19.4% from the prior year.
• Cash & Equivalents came in at $451.2 million for Q1 2026 at Herbalife, up from $353.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $595.5 million in Q4 2023 to a low of $305.5 million in Q3 2025.
• The 5-year median for Cash & Equivalents is $451.2 million (2026), against an average of $458.0 million.
• Across the five-year window, Cash & Equivalents tumbled 30.3% in 2022 and advanced 28.55% in 2026, its largest moves.
• Herbalife's Cash & Equivalents stood at $516.3 million in 2022, then grew by 15.34% to $595.5 million in 2023, then declined by 26.43% to $438.1 million in 2024, then fell by 19.4% to $353.1 million in 2025, then grew by 27.78% to $451.2 million in 2026.
• The last three Cash & Equivalents figures came in at $451.2 million (Q1 2026), $353.1 million (Q4 2025), and $305.5 million (Q3 2025), per Business Quant data.